PHARMACOKINETICS OF D(+)-USNIC ACID IN RABBITS AFTER INTRAVENOUS AND ORAL-ADMINISTRATION

被引:0
|
作者
KRISHNA, DR [1 ]
VENKATARAMANA, D [1 ]
机构
[1] KAKATIYA UNIV, COLL PHARMACEUT SCI, WARANGAL 506009, ANDHRA PRADESH, INDIA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmacokinetics of D(+)-usnic acid-a lichen antitubercular, antitumor, and enzyme-inhibiting agent-was studied in rabbits following intravenous or oral administration of 5 and 20 mg/kg body weight doses, respectively. Plasma samples were collected at different time intervals, and usnic acid was determined by HPLC. Plasma usnic acid levels following intravenous administration showed a triexponential elimination with a mean +/- SD terminal half-life of 10.7 +/- 4.6 hr. The volume of distribution of the central compartment and systemic clearance were 43.9 +/- 21.3 ml/kg and 12.2 +/- 3.0 ml/hr/kg, respectively. Pharmacokinetic parameters obtained, based on compartmental and noncompartmental approaches, were comparable. Plasma concentration data obtained after oral administration were analyzed using a noncompartmental method. Peak plasma level (C(max)) of 32.5 +/- 6.8 mug/ml was achieved in 12.2 +/- 3.8 hr (t(max)). Mean absolute bioavailability of usnic acid following oral administration was 77.8%.
引用
收藏
页码:909 / 911
页数:3
相关论文
共 50 条
  • [1] PHARMACOKINETICS OF D(+)-USNIC ACID IN RABBITS AFTER INTRAVENOUS ADMINISTRATION
    VENKATARAMANA, D
    KRISHNA, DR
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1993, 18 (02) : 161 - 163
  • [2] PHARMACOKINETICS AND METABOLISM OF DILTIAZEM IN RABBITS AFTER A SINGLE INTRAVENOUS OR SINGLE ORAL-ADMINISTRATION
    YEUNG, PKF
    MOSHER, SJ
    POLLAK, PT
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1991, 16 (01) : 69 - 74
  • [3] PHARMACOKINETICS OF ACYCLOVIR AFTER INTRAVENOUS AND ORAL-ADMINISTRATION
    DEMIRANDA, P
    BLUM, MR
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 12 : 29 - 37
  • [4] PHARMACOKINETICS OF DILTIAZEM AFTER INTRAVENOUS AND ORAL-ADMINISTRATION
    HERMANN, P
    RODGER, SD
    REMONES, G
    THENOT, JP
    LONDON, DR
    MORSELLI, PL
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (03) : 349 - 352
  • [5] PHARMACOKINETICS OF FTORAFUR AFTER INTRAVENOUS AND ORAL-ADMINISTRATION
    ANTTILA, MI
    SOTANIEMI, EA
    KAIRALUOMA, MI
    MOKKA, RE
    SUNDQUIST, HT
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1983, 10 (03) : 150 - 153
  • [6] PHARMACOKINETICS OF BUFLOMEDIL AFTER INTRAVENOUS AND ORAL-ADMINISTRATION
    REY, E
    BARRIER, G
    DATHIS, P
    DELAUTURE, D
    RICHARD, MO
    LIRZIN, JP
    SUREAU, C
    OLIVE, G
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1980, 18 (10) : 437 - 441
  • [7] PHARMACOKINETICS OF AMIODARONE AFTER INTRAVENOUS AND ORAL-ADMINISTRATION
    ANASTASIOUNANA, M
    LEVIS, GM
    MOULOPOULOS, S
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1982, 20 (11) : 524 - 529
  • [8] METHYLPREDNISOLONE PHARMACOKINETICS AFTER INTRAVENOUS AND ORAL-ADMINISTRATION
    ALHABET, SMH
    ROGERS, HJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (03) : 285 - 290
  • [9] PHARMACOKINETICS OF AMIODARONE AFTER INTRAVENOUS AND ORAL-ADMINISTRATION
    ANDREASEN, F
    AGERBAEK, H
    BJERREGAARD, P
    GOTZSCHE, H
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 19 (04) : 293 - 299
  • [10] PHARMACOKINETICS OF ETOFYLLINE AFTER INTRAVENOUS AND ORAL-ADMINISTRATION TO HUMANS
    ZUIDEMA, J
    VERHOEVEN, J
    MERKUS, FWHM
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1981, 19 (07) : 310 - 313